
Talks for Novonor to sell a controlling stake in petrochemical firm Braskem (BAK) to a fund backed by Nelson Tanure are continuing despite the lapse of an exclusive negotiation window, with resolution of environmental liabilities from Braskem's salt mines remaining the key sticking point for the buyer. A rival bid from private equity firm IG4 Capital is also emerging, aiming to swap Novonor's bank debt for Braskem shares. Braskem shares rose approximately 2.4% on the news, reflecting ongoing market interest in the protracted sale process.
The sale process for Novonor's controlling stake in Braskem (BAK) remains active but is defined by significant uncertainty. While negotiations with a fund backed by Nelson Tanure are continuing past the 90-day exclusivity deadline, a major impediment persists: the resolution of substantial environmental liabilities tied to Braskem's salt mining operations in Maceio. The Tanure fund has explicitly stated that a deal is conditional upon being fully insulated from these liabilities, a "sine qua non" condition that has so far prevented an agreement. The continuation of talks signals that a deal is not off the table, providing some stability for Novonor's creditors. However, the situation is further complicated by the emergence of a potential rival bid from private equity firm IG4 Capital, which proposes to acquire the stake by consolidating Novonor's bank debt and exchanging it for Braskem shares. Braskem's stock rose 2.4% on the news, but this performance merely tracked the broader Bovespa index, indicating a market that is pricing in the ongoing M&A potential but remains cautious given the unresolved legal and financial complexities.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
mixed
Sentiment Score
0.00
Ticker Sentiment